You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

LORATADINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for loratadine and what is the scope of patent protection?

Loratadine is the generic ingredient in eleven branded drugs marketed by Bayer Healthcare Llc, Aurobindo Pharma, Bionpharma, Marksans Pharma, Strides Pharma, Taro, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Lannett Co Inc, Perrigo, Pharm Assoc, Ranbaxy Labs Ltd, Teva, Wockhardt Bio Ag, Perrigo Pharma Intl, Sun Pharm, Fdn Consumer, Actavis Labs Fl Inc, Glaxosmithkline, Rubicon, Tenshi, Sun Pharm Inds Ltd, Anda Repository, Apotex Inc, Granules, Hetero Labs Ltd V, Mylan, Norvium Bioscience, Pld Acquisitions Llc, Unique Pharm, Heritage Pharma, and P And L, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for loratadine. One hundred and fifty-five suppliers are listed for this compound.

Drug Prices for LORATADINE

See drug prices for LORATADINE

Drug Sales Revenue Trends for LORATADINE

See drug sales revenues for LORATADINE

Recent Clinical Trials for LORATADINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AHS Cancer Control AlbertaPhase 2
King Edward Medical UniversityPhase 4
Ain Shams UniversityPhase 3

See all LORATADINE clinical trials

Medical Subject Heading (MeSH) Categories for LORATADINE

US Patents and Regulatory Information for LORATADINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd Iii LORATADINE loratadine SYRUP;ORAL 210409-001 May 7, 2021 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience LORATADINE loratadine TABLET;ORAL 075790-001 Nov 7, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan LORATADINE loratadine TABLET;ORAL 076154-001 Aug 20, 2003 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
P And L LORATADINE AND PSEUDOEPHEDRINE SULFATE loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 075706-001 Feb 21, 2003 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd LORATADINE loratadine SYRUP;ORAL 208931-001 Jun 29, 2018 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Ltd LORATADINE loratadine TABLET;ORAL 076134-001 Aug 18, 2003 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LORATADINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Healthcare Llc CLARITIN loratadine SYRUP;ORAL 020641-002 Nov 27, 2002 ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc CLARITIN REDITABS loratadine TABLET, ORALLY DISINTEGRATING;ORAL 020704-002 Nov 27, 2002 ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc CLARITIN REDITABS loratadine TABLET, ORALLY DISINTEGRATING;ORAL 020704-002 Nov 27, 2002 ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc CLARITIN loratadine TABLET;ORAL 019658-002 Nov 27, 2002 ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc CLARITIN loratadine TABLET;ORAL 019658-002 Nov 27, 2002 ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc CLARITIN loratadine SYRUP;ORAL 020641-002 Nov 27, 2002 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.